Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship.
about
Multiple molecular targets of resveratrol: Anti-carcinogenic mechanismsPhytochemicals for the Management of MelanomaRole of Natural Stilbenes in the Prevention of CancerFormation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective EffectsPotential implication of the chemical properties and bioactivity of nitrone spin traps for therapeuticsResveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells.Antitumor effects of 3,3',4,4',5,5'-hexahydroxystilbene in HL-60 human promyelocytic leukemia cells.Aza-derivatives of resveratrol are potent macrophage migration inhibitory factor inhibitors.Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites.2,3',4,4',5'-Pentamethoxy-trans-stilbene, a resveratrol derivative, inhibits colitis-associated colorectal carcinogenesis in miceThe Use of 3,5,4'-Tri-O-acetylresveratrol as a Potential Pro-drug for Resveratrol Protects Mice from γ-Irradiation-Induced Death.Roles of SIRT1 in the acute and restorative phases following induction of inflammation.Evaluation of Anticancer, Antioxidant, and Possible Anti-inflammatory Properties of Selected Medicinal Plants Used in Indian Traditional Medication.Novel hybrid nocodazole analogues as tubulin polymerization inhibitors and their antiproliferative activityPleiotropic mechanisms facilitated by resveratrol and its metabolites.High Potency of a Novel Resveratrol Derivative, 3,3',4,4'-Tetrahydroxy-trans-stilbene, against Ovarian Cancer Is Associated with an Oxidative Stress-Mediated Imbalance between DNA Damage Accumulation and RepairTrans-resveratrol alters mammary promoter hypermethylation in women at increased risk for breast cancer.Resveratrol: French paradox revisited.PRACTICAL PREPARATION OF RESVERATROL 3-O-β-D-GLUCURONIDE.Resveratrol directly targets COX-2 to inhibit carcinogenesis.Expression of CYP1A1, CYP1B1 and MnSOD in a panel of human cancer cell linesBioactivity and structure of biophenols as mediators of chronic diseases.Evaluation of anti-inflammatory activity of selected medicinal plants used in Indian traditional medication system in vitro as well as in vivo.Synthetic resveratrol analogue, 3,3',4,4',5,5'-hexahydroxy-trans-stilbene, accelerates senescence in peritoneal mesothelium and promotes senescence-dependent growth of gastrointestinal cancers.3,4,5,4'-trans-tetramethoxystilbene (DMU-212) modulates the activation of NF-κB, AP-1, and STAT3 transcription factors in rat liver carcinogenesis induced by initiation-promotion regimen.Resveratrol commonly displays hormesis: occurrence and biomedical significance.Chemopreventive effects of resveratrol and resveratrol derivatives.The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's diseaseSelective COX-2 Inhibitors: A Review of Their Structure-Activity Relationships.Metabolomics of cancer cell cultures to assess the effects of dietary phytochemicals.Direct molecular targets of resveratrol: identifying key interactions to unlock complex mechanisms.Resveratrol (3,5,4'-trihydroxystilbene) and its properties in oral diseases.Food Polyphenols Fail to Cause a Biologically Relevant Reduction of COX-2 Activity.Differential effects of resveratrol and its natural analogs, piceatannol and 3,5,4'-trans-trimethoxystilbene, on anti-inflammatory heme oxigenase-1 expression in RAW264.7 macrophages.Influence of glucuronidation and reduction modifications of resveratrol on its biological activities.Impact of wines and wine constituents on cyclooxygenase-1, cyclooxygenase-2, and 5-lipoxygenase catalytic activity.Synthesis and biological evaluation of asymmetric indole curcumin analogs as potential anti-inflammatory and antioxidant agents.Resveratrol and its synthetic derivatives exert opposite effects on mesothelial cell-dependent angiogenesis via modulating secretion of VEGF and IL-8/CXCL8.Resveratrol derivatives as a pharmacological tool.Bioavailable constituents/metabolites of pomegranate (Punica granatum L) preferentially inhibit COX2 activity ex vivo and IL-1beta-induced PGE2 production in human chondrocytes in vitro.
P2860
Q24648759-5B4BC41B-4504-4CE6-AB0C-CC1033551F67Q26766708-3552890D-460F-4ECD-818A-01EB232160A4Q26769976-7C3B9B9A-492C-47BF-809C-2C8447341284Q28468284-18976F96-130B-4D7D-8CAE-FDBC7235CF0CQ28818673-11481FE9-F656-4B15-B80C-F647B745920CQ33260568-50C31C28-7ED9-4EF6-A121-F6E227E6E04AQ33261565-35303113-1417-45EA-9C2E-C783CFF29A8FQ34018060-90822C4C-DF35-44A8-9931-E0AD3C1202F4Q34051374-3D813021-0421-4970-95A2-C51F67129686Q34124800-9CEBDBAE-8078-4124-BC99-E1065138C444Q34206752-57DB9742-ED8E-47BC-A867-C661BD9174DBQ34438754-7C6DE6CA-B005-4C93-9C9D-F70D641D6090Q34453873-1B004956-E4A5-4B45-AC9F-C0E9F9EE62C7Q35559938-12B915B7-4277-4D24-A75B-F15E82D5D0EBQ35692517-88438C76-296D-431A-81D3-20D327834E18Q35851696-0A5F3E7C-0C1C-4610-9E5C-C75B318312DEQ36082837-0EF2B5D0-BB94-4C5D-9BCD-0B60FF2BA5FCQ36099455-507FC7A9-1E9D-4D5E-92D1-5DADEB3276E1Q36176410-77298AD2-3AD8-4F33-941E-701D71D4E54CQ36926520-7DDF3301-2B4A-4B70-B332-2AB212AE486BQ37210214-7201BBD1-DCE8-4D8F-BCC2-48B70D5E0011Q37307695-532CB786-09C1-4497-B16E-1AD13CD58E08Q37346062-F68BD807-F244-4916-8FA9-86435057061AQ37375475-2D97D2A6-9008-4C5B-B09A-30DA965B44D5Q37735173-4E1F7717-64EF-4D81-BF37-FC8F86EF179FQ37813307-640E5AB8-1C1F-46CE-838E-70285FE0EE54Q37831936-AB5F6668-FF90-42CD-9BA4-2B3290B0E818Q37845675-6588813B-A620-4D09-AC00-8EBEFB4C670EQ38163980-3BEEA761-FDEE-47F3-A5C5-EA5B4D8BA235Q38480472-739B556B-F0D5-491C-B93B-B673746CA49DQ38534570-379753AC-ABE3-489A-AE73-B50FA0FD577FQ38663394-33578939-CBEF-4862-9985-35FDEBF7F575Q38830017-BA4BE67A-65DF-41BE-B0F6-A655D6CB77F4Q39124882-BC2E2A7E-228A-48EC-8333-0E4F0B552FECQ39147997-A54ACE00-4D47-45A2-B3D4-495ADCA86661Q39153607-230A4BEF-33BD-4065-B19D-E6B731D917ECQ39203484-3D73AFA1-1C7D-4F56-8C16-C2AA4E4AE793Q39373401-EB1C8022-1B8C-4C67-936A-D24F26E2D5ACQ39413479-44E9CC02-6AAE-4D48-93FC-701AF804FF20Q39520696-F0EBFB3F-E16E-47E8-8BC8-3542ECBFCC5C
P2860
Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Resveratrol analogues as selec ...... ructure-activity relationship.
@en
Resveratrol analogues as selec ...... ructure-activity relationship.
@nl
type
label
Resveratrol analogues as selec ...... ructure-activity relationship.
@en
Resveratrol analogues as selec ...... ructure-activity relationship.
@nl
altLabel
Resveratrol analogues as selec ...... tructure–activity relationship
@en
prefLabel
Resveratrol analogues as selec ...... ructure-activity relationship.
@en
Resveratrol analogues as selec ...... ructure-activity relationship.
@nl
P2093
P50
P1476
Resveratrol analogues as selec ...... ructure-activity relationship.
@en
P2093
Karin Pleban
Norbert Handler
Philipp Saiko
Thomas Erker
Walter Jäger
P304
P356
10.1016/J.BMC.2004.08.008
P407
P577
2004-11-01T00:00:00Z